Please use this identifier to cite or link to this item: https://doi.org/10.1530/eje-21-0366
Title: Metabolic effects of brown fat in transitioning from hyperthyroidism to euthyroidism
Authors: Sun, Lijuan
Goh, Hui Jen
Verma, Sanjay
Govindharajulu, Priya
Sadananthan, Suresh Anand
Michael, Navin
Jadegoud, Yaligar
Henry, Christiani Jeyakumar 
Velan, S. Sendhil 
Yeo, Pei Shan
Lee, Yingshan
Lim, Brenda Su Ping
Liew, Huiling
Chew, Chee Kian
Quek, Timothy Peng Lim
Shakoor, Shaikh A. K. K. Abdul
Hoi, Wai Han
Chan, Siew Pang 
Chew, Daniel Ek
Dalan, Rinkoo 
Leow, Melvin Khee Shing 
Issue Date: 1-Oct-2021
Publisher: BioScientifica Ltd.
Citation: Sun, Lijuan, Goh, Hui Jen, Verma, Sanjay, Govindharajulu, Priya, Sadananthan, Suresh Anand, Michael, Navin, Jadegoud, Yaligar, Henry, Christiani Jeyakumar, Velan, S. Sendhil, Yeo, Pei Shan, Lee, Yingshan, Lim, Brenda Su Ping, Liew, Huiling, Chew, Chee Kian, Quek, Timothy Peng Lim, Shakoor, Shaikh A. K. K. Abdul, Hoi, Wai Han, Chan, Siew Pang, Chew, Daniel Ek, Dalan, Rinkoo, Leow, Melvin Khee Shing (2021-10-01). Metabolic effects of brown fat in transitioning from hyperthyroidism to euthyroidism. European Journal of Endocrinology 185 (4) : 553-563. ScholarBank@NUS Repository. https://doi.org/10.1530/eje-21-0366
Rights: Attribution 4.0 International
Abstract: Objective: Brown adipose tissue (BAT) controls metabolic rate through thermogenesis. As its regulatory factors during the transition from hyperthyroidism to euthyroidism are not well established, our study investigated the relationships between supraclavicular brown adipose tissue (sBAT) activity and physiological/metabolic changes with changes in thyroid status. Design: Participants with newly diagnosed Graves' disease were recruited. A thionamide antithyroid drug (ATD) such as carbimazole (CMZ) or thiamazole (TMZ) was prescribed in every case. All underwent energy expenditure (EE) measurement and supraclavicular infrared thermography (IRT) within a chamber calorimeter, as well as 18F-fluorodeoxyglucose (18F-FDG) positron-emission tomography/magnetic resonance (PET/MR) imaging scanning, with clinical and biochemical parameters measured during hyperthyroidism and repeated in early euthyroidism. PET sBAT mean/maximum standardized uptake value (SUV mean/max), MR supraclavicular fat fraction (sFF) and mean temperature (Tscv) quantified sBAT activity. Results: Twenty-one (16 female/5 male) participants aged 39.5 ± 2.5 years completed the study. The average duration to attain euthyroidism was 28.6 ± 2.3 weeks. Eight participants were BAT-positive while 13 were BAT-negative. sFF increased with euthyroidism (72.3 ± 1.4% to 76.8 ± 1.4%; P < 0.01), but no changes were observed in PET SUV mean and Tscv. Significant changes in serum-free triiodothyronine (FT 3) levels were related to BAT status (interaction P value = 0.04). FT3 concentration at hyperthyroid state was positively associated with sBAT PET SUV mean (r = 0.58, P = 0.01) and resting metabolic rate (RMR) (P < 0.01). Conclusion: Hyperthyroidism does not consistently lead to a detectable increase in BAT activity. FT3 reduction during the transition to euthyroidism correlated with BAT activity. © 2021 The authors.
Source Title: European Journal of Endocrinology
URI: https://scholarbank.nus.edu.sg/handle/10635/233829
ISSN: 0804-4643
DOI: 10.1530/eje-21-0366
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1530_eje-21-0366.pdf937.31 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons